NTRK2 and stroke disorder: For example, 7,8-dihydroxyflavone, a high-affinity TrkB agonist, was found to inhibit kainic acid-induced toxicity, decrease infarct volume following experimental stroke in a TrkB-dependent manner, and be neuroprotective in an animal model of Parkinson's disease [50].